 Connection
Kyle Rove to Treatment Outcome
This is a "connection" page, showing publications Kyle Rove has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.360 |
|
|
|
-
Chan M, Blanchette E, Rove KO. Pediatric Patients Undergoing Enterocystoplasty and Risk of Metabolic Disease: A Single Center Retrospective Study. Neurourol Urodyn. 2026 Jan; 45(1):225-230.
Score: 0.083
-
Harris KT, Hwang C, Caldwell B, Vemulakonda V, Wood D, Wilcox DT, Rove KO. Use of incisional negative pressure wound therapy in reconstructive pediatric and young adult urology to reduce surgical site occurrences: A pilot study. J Pediatr Urol. 2025 Oct; 21(5):1306-1312.
Score: 0.079
-
Rove KO, Crawford ED, Perachino M, Morote J, Klotz L, Lange PH, Andriole GL, Matsumoto AM, Taneja SS, Eisenberger MA, Reis LO. Maximal testosterone suppression in prostate cancer--free vs total testosterone. Urology. 2014 Jun; 83(6):1217-22.
Score: 0.037
-
Rove KO, Crawford ED. Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer. Curr Opin Urol. 2013 May; 23(3):208-13.
Score: 0.035
-
Rove KO, Crawford ED. Dutasteride: novel milestones in prostate cancer chemoprevention. Drugs Today (Barc). 2011 Feb; 47(2):135-44.
Score: 0.030
-
Rove KO, Sullivan KF, Crawford ED. High-intensity focused ultrasound: ready for primetime. Urol Clin North Am. 2010 Feb; 37(1):27-35, Table of Contents.
Score: 0.028
-
Tasian GE, Chu DI, Nelson CP, DeFoor WR, Ziemba JB, Huang J, Luan X, Kurtz M, Ching CB, Dangle P, Schaeffer AJ, Sturm R, Wu W, Bayne C, Fernandez N, Chua ME, DeMarco R, Ellsworth P, Augelli B, Bi-Karchin J, McCune RD, Vatsky S, Back S, Wang Z, Beck H, Kurth A, Kurth L, Pleskoff A, Forrest CB, Ellison JS, Rove K, Sparks S, Nelson E, Schlomer B, Krill A, Tong CMC, Taylor A, Ramachandra P, Stec A, Casale P, Coplen D, Janzen N, Bagley K, Denburg MR, Dickinson K, Laberee R, Lorenzo M, Selman-Fermin A, Dos Santos J, Grant C, Kraft K, Meenakshi-Sundaram B. Ureteroscopy vs Shockwave Lithotripsy to Remove Kidney Stones in Children and Adolescents: A Nonrandomized Clinical Trial. JAMA Netw Open. 2025 Aug 01; 8(8):e2525789.
Score: 0.020
-
Ellison JS, Chu DI, Nelson CP, DeFoor WR, Ziemba J, Huang J, Luan X, Kurtz M, Ching CB, Dangle PP, Schaeffer AJ, Sturm R, Wu W, Bayne C, Fernandez N, Chua ME, DeMarco R, Ellsworth P, Augelli B, Bi-Karchin J, McCune RD, Vatsky S, Back S, Wang Z, Beck H, Kurth A, Kurth L, Pleskoff A, Forrest CB, Tasian GE, Rove K, Sparks S, Nelson E, Schlomer B, Krill A, Tong CMC, Taylor A, Ramachandra P, Stec A, Casale P, Coplen D, Janzen N, Bagley K, Denburg M, Dickinson K, Laberee R, Lorenzo M, Selman-Fermin A, Dos Santos J, Grant C, Kraft K, Meenakshi-Sundaram B. Percutaneous Nephrolithotomy vs Ureteroscopy for Kidney Stones in Children. JAMA Netw Open. 2025 06 02; 8(6):e2516749.
Score: 0.020
-
Tasian GE, Maltenfort MG, Rove K, Ching CB, Ramachandra P, DeFoor B, Fernandez N, Forrest CB, Ellison JS. Ureteral Stent Placement Prior to Definitive Stone Treatment Is Associated With Higher Postoperative Emergency Department Visits and Opioid Prescriptions for Youth Having Ureteroscopy or Shock Wave Lithotripsy. J Urol. 2023 06; 209(6):1194-1201.
Score: 0.017
-
Chalmers DJ, Rove KO, Wiedel CA, Tong S, Siparsky GL, Wilcox DT. Clean intermittent catheterization as an initial management strategy provides for adequate preservation of renal function in newborns with persistent cloaca. J Pediatr Urol. 2015 Aug; 11(4):211.e1-4.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|